Bahgat Nermine Ahmed, Kamal Manal Mohamed, Abdelaziz Ashraf Omar, Mohye Mohamed Ahmed, Shousha Hend Ibrahim, ahmed Mae Mohamed, Elbaz Tamer Mahmoud, Nabil Mohamed Mahmoud
Clinical and Chemical Pathology Department, Faculty of medicine, Cairo University, Egypt E-mail :
Asian Pac J Cancer Prev. 2015;16(12):5025-30. doi: 10.7314/apjcp.2015.16.12.5025.
Immunoregulatory cytokines have an influence on hepatitis C virus (HCV) infection outcome. This study aimed to determine whether single nucleotide polymorphisms (SNP) in IFN- γ and IL-10 genes are associated with susceptibility and/or are markers of prognosis regarding chronic hepatitis C outcomes. IFN γ (+874T/A) and IL-10 (-1082G/A) genotypes were determined in 75 HCV genotype 4 patients with different disease severities (chronic hepatitis, n=25, liver cirrhosis and hepatocellular carcinoma (HCC) on top of liver cirrhosis, n=50) and 25 healthy participants using allele-specific polymerase chain reaction. No statistical differences in allele or genotype distributions of IFN γ and IL-10 genes were detected between patients and controls or between patientgroups. No significant difference in the frequency of IL-10 SNP at position -1082 or IFN-γ at position +874T/A was found between chronic HCV genotype 4 and with progression of disease severity in liver cirrhosis or HCC. In conclusion; interferon-γ and interleukin-10 gene polymorphisms are not predictors of disease progression in patients with chronic hepatitis C (Genotype-4).
免疫调节细胞因子对丙型肝炎病毒(HCV)感染的结果有影响。本研究旨在确定IFN-γ和IL-10基因中的单核苷酸多态性(SNP)是否与慢性丙型肝炎结局的易感性和/或预后标志物相关。采用等位基因特异性聚合酶链反应,在75例不同疾病严重程度的HCV基因4型患者(慢性肝炎,n = 25;肝硬化以及肝硬化基础上的肝细胞癌(HCC),n = 50)和25名健康参与者中测定IFNγ(+874T/A)和IL-10(-1082G/A)基因型。在患者与对照组之间或患者组之间,未检测到IFNγ和IL-10基因的等位基因或基因型分布存在统计学差异。在慢性HCV基因4型患者中,以及在肝硬化或HCC疾病严重程度进展过程中,未发现-1082位IL-10 SNP或+874T/A位IFN-γ的频率存在显著差异。总之,干扰素-γ和白细胞介素-10基因多态性不是慢性丙型肝炎(基因4型)患者疾病进展的预测指标。